Registry collecting information on people with blood clotting and bleeding disorders
Collects health information from people with hemophilia, thrombosis, sickle cell disease, or Glanzmann thrombasthenia.
Key facts
- Who runs it
- American Thrombosis and Hemostasis Network
- Where
- Hickory, United StatesSee the site
- Trial code
- Registry title
- ATHNdataset Registry
- Status
- Recruiting
- People taking part
- 200,000 people, planned
- Started
- 25 Oct 2024
- Expected to end
- 31 Oct 2055
- Type of study
- Observational
- Record updated
- 21 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is open to people who are checked for, or may have, a blood disorder and who visit an ATHN Affiliate. Any age can join.
- Age
- Any age
- Sex
- All sexes
- Disease stage
- Anyone evaluated for a blood disorder or who may have one
Main reasons for not taking part
- People who cannot give consent or assent, and have no Legally Authorized Representative to consent for them
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Any participant evaluated for or the potential to have a blood disorder who has an encounter with an ATHN Affiliate
- Participants of any age
- Participant is able to provide consent or assent; a Legally Authorized Representative (LAR) may provide consent on a participant's behalf if a participant is unable to provide self-consent
Who cannot take part
- Any participant unable to provide consent or assent to participate in the ATHNdataset
Where in United States
- American Thrombosis and Hemostasis NetworkHickory, United StatesContact: Carol Fedor, ND, RNTaking people
About the trial
What the trial wants to find out
The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems.
Read full original descriptionShow less
Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.
The group in the trial
- Blood Disorders
The ATHNdataset is a large, robust real-world registry that can be queried to produce curated subsets of data to support clinical care, outcomes analysis, safety monitoring, practice of treatment, advocacy, public health reporting, quality improvement projects, and research initiatives. Initiatives relying on the ATHNdataset may focus on gaining a greater understanding of blood disorders, the complications of these disorders, their social and economic costs, and the effectiveness of treatments. The population includes all individuals diagnosed with or suspected to have a blood disorder. Participants will contribute data gathered during care encounters with an ATHN Affiliate.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- American Thrombosis and Hemostasis Network ATHNdataset Registry
- Plain-language title
- Registry collecting information on people with blood clotting and bleeding disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 21 April 2026